WAKIX is a prescription medicine used to treat excessive daytime sleepiness (EDS) or sudden onset of weak or paralyzed muscles (cataplexy) in adults with narcolepsy. It is a first-of-its-kind medication that increases histamine levels in the brain. The first and only once-daily tablet that is FDA approved to treat EDS or cataplexy in adults with narcolepsy, that is not a controlled substance.

Information you need to know about WAKIX:

• WAKIX is distributed by Harmony Biosciences in the USA and Paladin Labs in Canada.
• Wakix is distributed as 5mg and 20mg pitolisant hydrochloride tablets in Canada.
• In the USA Wakix tablets contain 4.45mg and 17.8mg of pitolisant.
• It is not uncommon for strengths to be listed differently such as 4.45mg of pitolisant and 5mg of pitolisant hydrochloride.
• Wakix has several potential drug interactions including interacting with other antihistamine medications and agents that can cause QT prolongation. QT prolongation leads to an increased risk of cardiac arrhythmia. Always discuss new medications with your pharmacist.

Notice: The above information is an educational aid only. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.